Overview

A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema

Status:
Completed
Trial end date:
2013-04-15
Target enrollment:
Participant gender:
Summary
This retrospective chart review study will describe the history of patients with retinal disease with macular edema to whom OZURDEX® (dexamethasone intravitreal implant) is administered, and assess treatment patterns and visual outcomes. OZURDEX® was previously administered according to general clinical practice.
Details
Lead Sponsor:
Allergan
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate